Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorWonju Severance Christian Hospital
About this trial
By using genetic information we could predict the prevalence of mood disorder and response to treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
CKD patients aged 18 to 90 years
Disqualifiers
no CKD patients, aged below 18 or above 90 years
Trial population
Patients with CKD without history of mood disorder
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Antidepressants
Other interventioncontrol
Treatment groups
300 Participants
are divided into 1 treatment groupGroup A: chronic kidney with mood disorder1 intervention
Trial outcomes
Primary outcomes
1
Prevalence of depression
Prevalence of depression
Time frame
10 yearsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: